Algo version: 0.98b
Sinco Pharmaceuticals is listed at the HKSE Exchange
Sinco Pharmaceuticals [6833.HK]
HKSE Sector: Healthcare Industry:Advertising Agencies

Is Sinco Pharmaceuticals stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Sinco Pharmaceuticals pays dividends. Last time was Tuesday 4th of June 2024 where the investors holding the stock on Monday 20th of May 2024 were paid HKD0.0039 per share. Over the last 3 times between 2016 and 2024, Sinco Pharmaceuticals has paid HKD0.017 with an average of HKD0.01 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Sinco Pharmaceuticals 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was HKD0.300, you would have made a loss of HKD-0.0980 per share or -32.67%

No, the average daily trading liquidity for Sinco Pharmaceuticals is HKD95 361 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Sinco Pharmaceuticals has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 1.41, the company's ability to pay off the debt is good. The company has a very low net profit margin of 1.67%, which is challenging.

We have calculated the inflation risk for Sinco Pharmaceuticals to be low [0.35 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.